LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 81.05 | 84.90 | 56 | 8863 | 0.0063 | -0.0602 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 81.05 | 84.90 | 1 | 8863 | 0.0001 | -0.4843 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 81.05 | 84.90 | 588 | 8863 | 0.0663 | 0.3345 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.75 | 84.90 | 1 | 8621 | 0.0001 | -0.4864 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.75 | 84.90 | 37 | 8621 | 0.0043 | -0.1171 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.75 | 84.90 | 1 | 8621 | 0.0001 | -0.4864 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 82.75 | 84.90 | 591 | 8621 | 0.0686 | 0.3379 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.45 | 84.90 | 1 | 8254 | 0.0001 | -0.4896 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.45 | 84.90 | 25 | 8254 | 0.0030 | -0.1690 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.45 | 84.90 | 1 | 8254 | 0.0001 | -0.4896 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 84.45 | 84.90 | 551 | 8254 | 0.0667 | 0.3274 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.16 | 84.90 | 1 | 8141 | 0.0001 | -0.4907 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.16 | 84.90 | 13 | 8141 | 0.0016 | -0.2480 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.16 | 84.90 | 1 | 8141 | 0.0001 | -0.4907 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 86.16 | 84.90 | 551 | 8141 | 0.0677 | 0.3286 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 87.86 | 84.90 | 1 | 7680 | 0.0001 | -0.4951 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 87.86 | 84.90 | 9 | 7680 | 0.0012 | -0.2920 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 87.86 | 84.90 | 1 | 7680 | 0.0001 | -0.4951 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 87.86 | 84.90 | 515 | 7680 | 0.0671 | 0.3197 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 89.57 | 84.90 | 1 | 7494 | 0.0001 | -0.4970 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 89.57 | 84.90 | 5 | 7494 | 0.0007 | -0.3548 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 89.57 | 84.90 | 1 | 7494 | 0.0001 | -0.4970 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 89.57 | 84.90 | 486 | 7494 | 0.0648 | 0.3099 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 91.27 | 84.90 | 1 | 7420 | 0.0001 | -0.4977 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 91.27 | 84.90 | 1 | 7420 | 0.0001 | -0.4977 | MN20160318_Q02 | F05 |